|
Volumn 437, Issue 7061, 2005, Pages 942-943
|
Playing dirty
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DISEASE CONTROL;
DISEASES;
PATIENT TREATMENT;
COMPLEX DISEASES;
DRUG DOSAGE;
ACETYLSALICYLIC ACID;
ANTINEOPLASTIC AGENT;
AXITINIB;
CLOZAPINE;
GEFITINIB;
IMATINIB;
SORAFENIB;
SUNITINIB;
UNCLASSIFIED DRUG;
VANDETANIB;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
MEDICINE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
KIDNEY CANCER;
LEUKEMIA;
LUNG CANCER;
MEDICAL RESEARCH;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
SHORT SURVEY;
SIDE EFFECT;
THYROID CANCER;
ANIMAL;
ARTICLE;
CARDIOVASCULAR DISEASE;
DEPRESSION;
DRUG APPROVAL;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG SCREENING;
ENZYME SPECIFICITY;
FOOD AND DRUG ADMINISTRATION;
METHODOLOGY;
NEOPLASM;
SENSITIVITY AND SPECIFICITY;
THERAPY;
UNITED STATES;
ANIMALS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
CLOZAPINE;
DEPRESSION;
DRUG APPROVAL;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
DRUG INDUSTRY;
HUMANS;
NEOPLASMS;
PIPERAZINES;
PYRIMIDINES;
QUINAZOLINES;
SENSITIVITY AND SPECIFICITY;
SUBSTRATE SPECIFICITY;
THERAPEUTICS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 27144443099
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/437942a Document Type: Short Survey |
Times cited : (325)
|
References (7)
|